ALBERT BOURLA - 25 Feb 2026 Form 4 Insider Report for PFIZER INC (PFE)

Role
Chairman & CEO, Director
Signature
/s/ Shanice A. Reid, by power of atty., for Albert Bourla
Issuer symbol
PFE
Transactions as of
25 Feb 2026
Net transactions value
+$3,823,735
Form type
4
Filing time
27 Feb 2026, 18:34:07 UTC
Previous filing
17 Feb 2026
Next filing
05 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BOURLA ALBERT Chairman & CEO, Director 66 HUDSON BOULEVARD EAST, ATTN: CORPORATE SECRETARY, NEW YORK /s/ Shanice A. Reid, by power of atty., for Albert Bourla 27 Feb 2026 0001595703

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PFE Common Stock Options Exercise $16,626,791 +491,626 +132% $33.82 864,215 25 Feb 2026 Direct F1
transaction PFE Common Stock Tax liability $224,928 -8,303 -0.96% $27.09 855,912 25 Feb 2026 Direct F2
transaction PFE Common Stock Tax liability $12,578,128 -467,241 -55% $26.92 388,671 25 Feb 2026 Direct F3, F4
holding PFE Common Stock 6,003 25 Feb 2026 By Rule 16b-3 Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Stock Appreciation Rights Options Exercise $0 -491,626 -100% $0.000000 0 25 Feb 2026 Common Stock 491,626 $33.82 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2 The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F3 The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F4 Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.